Mustang Bio, Inc. (MBIO)

Mustang Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	18.98	6.84	6.23	75.66	109.62	97.8
Cash & Short-Term Investments	18.98	6.84	6.23	75.66	109.62	97.8
Cash Growth	438.55%	9.71%	-91.76%	-30.98%	12.08%	59.26%
Other Receivables	0.22	0.4	3.88	0.3	0.05	0.02
Total Trade Receivables	0.22	0.4	3.88	0.3	0.05	0.02
Other Current Assets	0.16	1.37	1.23	2.9	2.04	1.72
Total Current Assets	19.36	8.61	11.35	78.85	111.71	99.53
Net Property, Plant & Equipment	-	0.45	4.81	12.31	12.1	9.12
Other Long-Term Assets	-	0.25	1.58	1.26	1.36	1.25
Total Assets	19.36	9.31	17.74	92.42	125.17	109.9
Accounts Payable	9.44	12.15	14.85	14.5	10.47	9.24
Current Portion of Leases	-	0.46	0.52	0.61	0.35	0.28
Total Current Liabilities	9.44	12.61	15.37	15.11	10.82	9.52
Long-Term Debt	-	-	-	27.44	-	-
Long-Term Leases	-	0.42	1.98	3.33	1.69	1.95
Other Long-Term Liabilities	0.15	0.15	0.27	0.27	0.27	-
Total Long-Term Liabilities	0.15	0.57	2.25	31.04	1.96	1.95
Total Liabilities	9.59	13.18	17.62	46.15	12.77	11.47
Common Stock	0	0.62	0.59	1.12	0.01	7.95
Additional Paid-in Capital	407.88	392.23	380.5	374.52	359.91	275.96
Retained Earnings	-398.11	-396.72	-380.97	-329.37	-251.84	-185.47
Shareholders' Equity	9.77	-3.87	0.12	46.27	112.4	98.44
Total Liabilities & Equity	19.36	9.31	17.74	92.42	125.17	109.9
Total Debt	-	0.88	2.5	31.38	2.03	2.23
Net Cash (Debt)	18.98	5.96	3.74	44.27	107.59	95.58
Net Cash Growth	218.47%	59.56%	-91.56%	-58.85%	12.57%	108.30%
Net Cash Per Share	5.35	9.78	21.72	0.29	873.88	1265.74
Book Value	9.77	-3.87	0.12	46.27	112.4	98.44
Book Value Per Share	2.76	-6.35	0.71	0.30	912.99	1303.61
Tangible Book Value	9.77	-3.87	0.12	46.27	112.4	98.44
Tangible Book Value Per Share	2.76	-6.35	0.71	0.30	912.99	1303.61

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q